(1) This instrument is the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2023.

(2) This instrument may also be cited as PB 104 of 2023.

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. Sections 1 to 4 and anything in this instrument not elsewhere covered by this table	The day after this instrument is registered.
2. Schedule 1	The day after this instrument is registered.
3. Schedule 2	1 April 2024.	1 April 2024
4. Schedule 3	The day after this instrument is registered.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority

This instrument is made under subsection 99ADHC(2) of the National Health Act 1953.

4 Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments—General

National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023

1 Section 5

Repeal the section, substitute:

5 Floor price of certain brands of pharmaceutical items

For the purposes of subsection 99ADHC(2) of the Act, paragraph 99ADHC(1)(c) of the Act applies to a brand mentioned in column 1 of an item in the following table of a pharmaceutical item that is the drug mentioned in column 2 of that table item, in the form mentioned in column 3 of that table item and with the manner of administration mentioned in column 4 of that table item.

Floor price of certain brands of pharmaceutical items
Column 1 Brand	Column 2 Drug	Column 3 Form	Column 4 Manner of administration
PKU squeezie	Amino acid formula with vitamins and minerals without phenylalanine	Oral gel 85 g, 30 (PKU squeezie)	Oral
Cal-500	Calcium	Tablet, chewable, 500 mg (as carbonate)	Oral
Dantrium	Dantrolene	Capsule containing dantrolene sodium hemiheptahydrate 25 mg	Oral
DBL Desferrioxamine Mesilate	Desferrioxamine	Powder for injection containing desferrioxamine mesilate 2 g	Injection
Cardizem	Diltiazem	Tablet containing diltiazem hydrochloride 60 mg	Oral
Diltiazem AN	Diltiazem	Tablet containing diltiazem hydrochloride 60 mg	Oral
Vasocardol	Diltiazem	Tablet containing diltiazem hydrochloride 60 mg	Oral
Triumeq	Dolutegravir with abacavir and lamivudine	Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg	Oral
Flucil	Flucloxacillin	Powder for injection 1 g (as sodium monohydrate)	Injection
Flucil	Flucloxacillin	Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL	Oral
Flucil	Flucloxacillin	Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL	Oral
DBL Heparin Sodium	Heparin	Injection 5,000 units (as sodium) in 0.2 ml	Injection
Moduretic	Hydrochlorothiazide with amiloride	Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg	Oral
Hymenoptera Honey Bee Venom	Insect allergen extract-honey bee venom	Injection set containing 550 micrograms with diluent	Injection
Hymenoptera Paper Wasp Venom	Insect allergen extract-paper wasp venom	Injection set containing 550 micrograms with diluent	Injection
Hymenoptera Yellow Jacket Venom	Insect allergen extract-yellow jacket venom	Injection set containing 550 micrograms with diluent	Injection
Toujeo Solostar	Insulin glargine	Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3	Injection
Toujeo Solostar	Insulin glargine	Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5	Injection
Lithicarb	Lithium	Tablet containing lithium carbonate 250 mg	Oral
Quilonum SR	Lithium	Tablet containing lithium carbonate 450 mg (slow release)	Oral
Penthrox	Methoxyflurane	Liquid for inhalation 999 mg per g, 3 ml (with inhaler)	Inhalation by mouth
Lyclear	Permethrin	Cream 50 mg per g, 30 g	Application
Pro-Cid	Probenecid	Tablet 500 mg	Oral
Asmol CFC-Free with dose counter	Salbutamol	Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by mouth
Ventolin CFC-Free with dose counter	Salbutamol	Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by mouth
Zempreon CFC-Free with dose counter	Salbutamol	Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by mouth
PHOSPHATE PHEBRA	Sodium acid phosphate	Tablet, compound effervescent, equivalent to 500 mg phosphorus	Oral
Lipistart	Triglycerides - medium chain, formula	Oral powder 400 g (Lipistart)	Oral
K.Quik	Triglycerides, medium chain	Oral liquid 225 mL, 15 (K.Quik)	Oral

Schedule 2—Amendments—Additional designated brands effective from 1 April 2024

National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023

1 Section 5 (after table item dealing with the brand PKU squeezie of the drug Amino acid formula with vitamins and minerals without phenylalanine in the form Oral gel 85 g, 30 (PKU squeezie))

Insert:

Kineret	Anakinra	Injection 100 mg in 0.67 mL single use pre-filled syringe	Injection
Bicillin L-A	Benzathine benzylpenicillin	Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre-filled syringe	Injection
Bicillin L-A	Benzathine benzylpenicillin	Injection containing 600,000 units benzathine benzylpenicillin tetrahydrate in 1.17 mL single use pre-filled syringe	Injection

2 Section 5 (after table item dealing with the brand Vasocardol of the drug Diltiazem in the form Tablet containing diltiazem hydrochloride 60 mg)

Insert:

ADT Booster

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

Injection 0.5 mL in pre-filled syringe

Injection

3 Section 5 (after table item dealing with the brand Triumeq of the drug Dolutegravir with abacavir and lamivudine in the form Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg)

Insert:

Estraderm MX 50	Estradiol	Transdermal patches 1.5 mg (as hemihydrate), 8	Transdermal
Estraderm MX 100	Estradiol	Transdermal patches 3 mg (as hemihydrate), 8	Transdermal
Estraderm MX 25	Estradiol	Transdermal patches 750 micrograms (as hemihydrate), 8	Transdermal

4 Section 5 (after table item dealing with the brand Quilonum SR of the drug Lithium in the form Tablet containing lithium carbonate 450 mg (slow release))

Insert:

OsmoLax

Macrogol 3350

Powder for oral solution 510 g

Oral

5 Section 5 (after table item dealing with the brand Penthrox of the drug Methoxyflurane in the form Liquid for inhalation 999 mg per g, 3 ml (with inhaler))

Insert:

Flagyl	Metronidazole	Suppositories 500 mg, 10	Rectal
Carbohydrate Free Mixture	Milk protein and fat formula with vitamins and minerals -- carbohydrate free	Oral powder 225 g (Carbohydrate Free Mixture)	Oral
MORPHINE SULFATE 15 mg/1 mL MEDSURGE	Morphine	Injection containing morphine sulfate pentahydrate 15 mg in 1 mL	Injection
MORPHINE SULFATE 30 mg/1 mL MEDSURGE	Morphine	Injection containing morphine sulfate pentahydrate 30 mg in 1 mL	Injection
Ditropan	Oxybutynin	Tablet containing oxybutynin hydrochloride 5 mg	Oral
Oxytrol	Oxybutynin	Transdermal patches 36 mg, 8	Transdermal

6 Section 5 (after table item dealing with the brand Lyclear of the drug Permethrin in the form Cream 50 mg per g, 30 g)

Insert:

Elidel

Pimecrolimus

Cream 10 mg per g, 15 g

Application

7 Section 5 (after table item dealing with the brand Pro-Cid of the drug Probenecid in the form Tablet 500 mg)

Insert:

Stemetil	Prochlorperazine	Injection containing prochlorperazine mesilate 12.5 mg in 1 mL	Injection
Aptamil Gold+ Pepti-Junior	Protein hydrolysate formula with medium chain triglycerides	Oral powder 450 g (Aptamil Gold+ Pepti-Junior)	Oral

8 Section 5 (after table item dealing with the brand Zempreon CFC-Free with dose counter of the drug Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation))

Insert:

Eldepryl

Selegiline

Tablet containing selegiline hydrochloride 5 mg

Oral

9 Section 5 (after table item dealing with the brand PHOSPHATE PHEBRA of the drug Sodium acid phosphate in the form Tablet, compound effervescent, equivalent to 500 mg phosphorus)

Insert:

Micolette

Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate

Enemas 3.125 g-450 mg-45 mg in 5 mL, 12

Rectal

10 Section 5 (after table item dealing with the brand K.Quik of the drug Triglycerides, medium chain in the form Oral liquid 225 mL, 15 (K.Quik))

Insert:

Epilim Liquid	Valproic acid	Oral liquid containing sodium valproate 200 mg per 5 mL, 300 mL	Oral
Epilim Syrup	Valproic acid	Oral solution containing sodium valproate 200 mg per 5 mL, 300 mL	Oral

Schedule 3—Repeals

National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2022

1 The whole of the instrument

Repeal the instrument.